Benta Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 1 Year 10 Months
- Last Filing with ROC 31 Mar 2024
About Benta Pharma
Benta Pharma Private Limited (BPPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 April 2023 (One year and ten months 15 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Paper Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Suresh Nandiraju and Benard Tannouri serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U21002TS2023PTC171849
- Company No.
171849
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Apr 2023
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Benta Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Nandiraju  | Additional Director | 31-Jul-2023 | Current |
Benard Tannouri  | Additional Director | 31-Jul-2023 | Current |
Financial Performance of Benta Pharma.
Enhance accessibility to Benta Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Benta Pharma?
Unlock access to Benta Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Clinsync Clinical Research Private LimitedSuresh Nandiraju is a mutual person
Osr Projects LlpSuresh Nandiraju is a mutual person
- Pharmarics Private Limited
Suresh Nandiraju is a mutual person
- Ala Realtors Private Limited
Suresh Nandiraju is a mutual person
- Omnicare Drugs India Private Limited
Suresh Nandiraju is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Benta Pharma?
Unlock and access historical data on people associated with Benta Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Benta Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Benta Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
